{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:clindamycin-phosphate-injection",
  "slug": "clindamycin-phosphate-injection",
  "title": "FDA shortage status: Clindamycin Phosphate Injection",
  "ingredient": "Clindamycin Phosphate Injection",
  "status": "current",
  "source_statuses": [
    "Current",
    "To Be Discontinued"
  ],
  "brand_names": [
    "CLEOCIN PHOSPHATE",
    "CLINDAMYCIN",
    "CLINDAMYCIN IN 5 PERCENT DEXTROSE",
    "CLINDAMYCIN PHOSPHATE"
  ],
  "therapeutic_categories": [
    "Anti-Infective"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS"
  ],
  "package_count": 26,
  "packages": [
    {
      "package_ndc": "0338-3410-50",
      "product_ndc": "0338-3410",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-9545-50",
      "product_ndc": "0338-9545",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-9549-50",
      "product_ndc": "0338-9545",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-3612-50",
      "product_ndc": "0338-3410",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-3814-50",
      "product_ndc": "0338-3410",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-9553-50",
      "product_ndc": "0338-9545",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-3051-02",
      "product_ndc": "0009-3051",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL) (NDC 0009-3051-02)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-0870-26",
      "product_ndc": "0009-0728",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "06/01/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-3051-02",
      "product_ndc": "0009-3051",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "06/01/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-4073-04",
      "product_ndc": "0009-3051",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL) (NDC 0009-4073-04)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-0775-26",
      "product_ndc": "0009-0728",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "06/01/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-4073-04",
      "product_ndc": "0009-3051",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "06/01/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-5095-06",
      "product_ndc": "0009-3051",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL) (NDC 0009-5095-06)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-0902-18",
      "product_ndc": "0009-0728",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "06/01/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-5095-06",
      "product_ndc": "0009-3051",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "06/01/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-0870-26",
      "product_ndc": "0009-0728",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-0775-26",
      "product_ndc": "0009-0728",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0009-0902-18",
      "product_ndc": "0009-0728",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Pharmacia & Upjohn Company LLC",
      "presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-115-02",
      "product_ndc": "25021-115",
      "company_name": "Sagent Pharmaceuticals",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-115-04",
      "product_ndc": "25021-115",
      "company_name": "Sagent Pharmaceuticals",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-115-06",
      "product_ndc": "25021-115",
      "company_name": "Sagent Pharmaceuticals",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAMUSCULAR",
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0781-3289-09",
      "product_ndc": "0781-3288",
      "company_name": "Sandoz Inc.",
      "manufacturer_name": "Sandoz Inc",
      "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72572-074-24",
      "product_ndc": "72572-074",
      "company_name": "Sandoz Inc.",
      "manufacturer_name": "Civica, Inc.",
      "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0781-3290-09",
      "product_ndc": "0781-3288",
      "company_name": "Sandoz Inc.",
      "manufacturer_name": "Sandoz Inc",
      "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72572-076-24",
      "product_ndc": "72572-074",
      "company_name": "Sandoz Inc.",
      "manufacturer_name": "Civica, Inc.",
      "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0781-3288-09",
      "product_ndc": "0781-3288",
      "company_name": "Sandoz Inc.",
      "manufacturer_name": "Sandoz Inc",
      "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/21/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 11,
    "Limited Availability": 3,
    "Unavailable": 6
  },
  "initial_posting_date": "03/21/2023",
  "latest_source_update": "08/18/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}